Disruption of histidine and energy homeostasis in chronic obstructive pulmonary disease

References

• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP28128970
   PubMed Web of Science ®Google Scholar
• Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J. 2008;31(4):869–873. doi:10.1183/09031936.0011170718216052
   PubMed Web of Science ®Google Scholar
• Cebron Lipovec N, Beijers RJ, van den Borst B, Doehner W, Lainscak M, Schols AM. The prevalence of metabolic syndrome in chronic obstructive pulmonary disease: a systematic review. COPD. 2016;13(3):399–406. doi:10.3109/15412555.2016.114073226914392
   PubMedGoogle Scholar
• Ubhi BK, Riley JH, Shaw PA, et al. Metabolic profiling detects biomarkers of protein degradation in COPD patients. Eur Respir J. 2012;40(2):345–355. doi:10.1183/09031936.0011241122183483
   PubMed Web of Science ®Google Scholar
• Naz S, Kolmert J, Yang M, et al. Metabolomics analysis identifies sex-associated metabotypes of oxidative stress and the autotaxin-lysoPA axis in COPD. Eur Respir J. 2017;49:6. doi:10.1183/13993003.02322-2016
   Web of Science ®Google Scholar
• Wang L, Tang Y, Liu S, et al. Metabonomic profiling of serum and urine by 1H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals. PLoS One. 2013;8(6):e65675. doi:10.1371/journal.pone.006567523755267
   PubMed Web of Science ®Google Scholar
• Chen Q, Deeb RS, Ma Y, Staudt MR, Crystal RG, Gross SS. Serum metabolite biomarkers discriminate healthy smokers from COPD smokers. PLoS One. 2015;10(12):e0143937. doi:10.1371/journal.pone.014393726674646
   PubMed Web of Science ®Google Scholar
• Serkova NJ, Standiford TJ, Stringer KA. The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am J Respir Crit Care Med. 2011;184(6):647–655. doi:10.1164/rccm.201103-0474CI21680948
   PubMed Web of Science ®Google Scholar
• Keil U, Kuulasmaa K. WHO MONICA project: risk factors. Int J Epidemiol. 1989;18(3 Suppl 1):S46–S55.2807707
   PubMed Web of Science ®Google Scholar
• Fang L, Gao P, Bao H, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med. 2018;6(6):421–430. doi:10.1016/S2213-2600(18)30103-629650407
   PubMed Web of Science ®Google Scholar
• Diao W, Shen N, Du Y, Qian K, He B. Characterization of throat microbial flora in smokers with or without COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:1933–1946. doi:10.2147/COPD.S14024328740374
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP22878278
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.0003480516055882
   PubMed Web of Science ®Google Scholar
• Gevenois PA, de Maertelaer V, De Vuyst P, Zanen J, Yernault JC. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med. 1995;152(2):653–657. doi:10.1164/ajrccm.152.2.76337227633722
   PubMed Web of Science ®Google Scholar
• Ambroggio L, Florin TA, Shah SS, et al. Emerging biomarkers of illness severity: urinary metabolites associated with sepsis and necrotizing methicillin-resistant staphylococcus aureus pneumonia. Pharmacotherapy. 2017;37(9):1033–1042. doi:10.1002/phar.197328632946
   PubMed Web of Science ®Google Scholar
• Stringer KA, Younger JG, McHugh C, et al. Whole blood reveals more metabolic detail of the human metabolome than serum as measured by 1H-NMR spectroscopy: implications for sepsis metabolomics. Shock. 2015;44(3):200–208. doi:10.1097/SHK.000000000000040626009817
   PubMed Web of Science ®Google Scholar
• Puskarich MA, Finkel MA, Karnovsky A, et al. Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock. Ann Am Thorac Soc. 2015;12(1):46–56. doi:10.1513/AnnalsATS.201409-415OC25496487
   PubMed Web of Science ®Google Scholar
• Nagana Gowda GA, Gowda YN, Raftery D. Expanding the limits of human blood metabolite quantitation using NMR spectroscopy. Anal Chem. 2015;87(1):706–715. doi:10.1021/ac503651e25485990
   PubMed Web of Science ®Google Scholar
• Thyagarajan B, Jacobs DR, Apostol GG, Smith LJ, Lewis CE, Williams OD. Plasma fibrinogen and lung function: the CARDIA Study. Int J Epidemiol. 2006;35(4):1001–1008. doi:10.1093/ije/dyl04916554379
   PubMed Web of Science ®Google Scholar
• Faner R, Tal-Singer R, Riley JH, et al. Lessons from ECLIPSE: a review of COPD biomarkers. Thorax. 2014;69(7):666–672. doi:10.1136/thoraxjnl-2013-20477824310110
   PubMed Web of Science ®Google Scholar
• Feng RN, Niu YC, Sun XW, et al. Histidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome: a randomised controlled trial. Diabetologia. 2013;56(5):985–994. doi:10.1007/s00125-013-2839-723361591
   PubMed Web of Science ®Google Scholar
• MacGlashan D Jr. Histamine: a mediator of inflammation. J Allergy Clin Immunol. 2003;112(4):S53–S59. doi:10.1016/S0091-6749(03)01877-314530789
   PubMedGoogle Scholar
• Storey J. A direct approach to false discovery rates. J Royal Stat Soc B. 2002;64(3):479–498. doi:10.1111/rssb.2002.64.issue-3
   Google Scholar
• Holmes E, Loo RL, Stamler J, et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature. 2008;453(7193):396. doi:10.1038/nature0688218425110
   PubMed Web of Science ®Google Scholar
• Xu T, Holzapfel C, Dong X, et al. Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study. BMC Med. 2013;11:60. doi:10.1186/1741-7015-11-6023497222
   PubMed Web of Science ®Google Scholar
• Gu F, Derkach A, Freedman ND, et al. Cigarette smoking behaviour and blood metabolomics. Int J Epidemiol. 2016;45(5):1421–1432. doi:10.1093/ije/dyv33026721601
   PubMed Web of Science ®Google Scholar
• Wang L, Tang Y, Liu S, et al. Metabonomic profiling of serum and urine by (1)H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals. PLoS One. 2013;8(6):e65675–e65675. doi:10.1371/journal.pone.006567523755267
   PubMed Web of Science ®Google Scholar
• de Laurentiis G, Paris D, Melck D, et al. Separating smoking-related diseases using NMR-based metabolomics of exhaled breath condensate. J Proteome Res. 2013;12(3):1502–1511. doi:10.1021/pr301171p23360153
   PubMed Web of Science ®Google Scholar
• Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80(3):1107–1213. doi:10.1152/physrev.2000.80.3.110710893433
   PubMed Web of Science ®Google Scholar
• Brosnan JT, Brosnan ME. Creatine: endogenous metabolite, dietary, and therapeutic supplement. Annu Rev Nutr. 2007;27:241–261. doi:10.1146/annurev.nutr.27.061406.09362117430086
   PubMed Web of Science ®Google Scholar
• Montesano A, Senesi P, Luzi L, Benedini S, Terruzzi I. Potential therapeutic role of L-carnitine in skeletal muscle oxidative stress and atrophy conditions. Oxid Med Cell Longev. 2015;2015:646171. doi:10.1155/2015/65975025838869
   PubMed Web of Science ®Google Scholar
• Wächter S, Vogt M, Kreis R, et al. Long-term administration of L-carnitine to humans: effect on skeletal muscle carnitine content and physical performance. Clin Chim Acta. 2002;318(1–2):51–61. doi:10.1016/S0009-8981(01)00804-X11880112
   PubMed Web of Science ®Google Scholar
• Celli BR, Locantore N, Tal-Singer R, et al. Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype. Eur Respir J. 2018;51(2):1702146. doi:10.1183/13993003.02146-201729437944
   PubMed Web of Science ®Google Scholar
• Young VR. Adult amino acid requirements: the case for a major revision in current recommendations. J Nutr. 1994;124(8 Suppl):1517s–1523s. doi:10.1093/jn/124.suppl_8.1517S8064412
   PubMed Web of Science ®Google Scholar
• Andersen HH, Elberling J, Arendt-Nielsen L. Human surrogate models of histaminergic and non-histaminergic itch. Acta Derm Venereol. 2015;95(7):771–777. doi:10.2340/00015555-214626015312
   PubMed Web of Science ®Google Scholar
• Watanabe M, Suliman ME, Qureshi AR, et al. Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality. Am J Clin Nutr. 2008;87(6):1860–1866. doi:10.1093/ajcn/87.6.186018541578
   PubMed Web of Science ®Google Scholar
• Wishart DS, Feunang YD, Marcu A, et al. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 2018;46(D1):D608–D617. doi:10.1093/nar/gkx108929140435
   PubMed Web of Science ®Google Scholar
• Panula P, Chazot PL, Cowart M, et al. International union of basic and clinical pharmacology. XCVIII. Histamine receptors. Pharmacol Rev. 2015;67(3):601–655. doi:10.1124/pr.114.01024926084539
   PubMed Web of Science ®Google Scholar
• Brown RH, Zerhouni EA, Hirshman CA. Reversal of bronchoconstriction by inhaled nitric oxide. Histamine versus methacholine. Am J Respir Crit Care Med. 1994;150(1):233–237. doi:10.1164/ajrccm.150.1.80257558025755
   PubMed Web of Science ®Google Scholar
• Hospers JJ, Postma DS, Rijcken B, Weiss ST, Schouten JP. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet. 2000;356(9238):1313–1317. doi:10.1016/S0140-6736(00)02815-411073020
   PubMed Web of Science ®Google Scholar
• Sparrow D, O’Connor G, Colton T, Barry CL, Weiss ST. The relationship of nonspecific bronchial responsiveness to the occurrence of respiratory symptoms and decreased levels of pulmonary function: the Normative Aging Study. Am Rev Respir Dis. 1987;135(6):1255–1260.3296893
   PubMed Web of Science ®Google Scholar
• Postma D, Rijcken B. The role of atopy and hyperresponsiveness in the development of COPD. Eur Respir Rev. 1997;(7)159–162.
   Google Scholar
• Hopp RJ, Townley RG, Biven RE, Bewtra AK, Nair NM. The presence of airway reactivity before the development of asthma. Am Rev Respir Dis. 1990;141(1):2–8. doi:10.1164/ajrccm/141.1.22404438
   PubMed Web of Science ®Google Scholar
• Jonker R, Deutz NE, Erbland ML, Anderson PJ, Engelen MP. Effectiveness of essential amino acid supplementation in stimulating whole body net protein anabolism is comparable between COPD patients and healthy older adults. Metabolism. 2017;69:120–129. doi:10.1016/j.metabol.2016.12.01028285641
   PubMed Web of Science ®Google Scholar